Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Want to know ways to sell products online quickly? Discover effective strategies that can help you generate sales fast.
21,381 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Broadcom and Marvell delivered AI-fueled earnings, but the race to sustain AI momentum hinges on scale, software, and...
Five of america's biggest banks kick off a pivotal earnings week. Here's what to watch as each reports and how the re...
Between Dec 31, 2025 and July 10, 2026, the Global X AI & Technology ETF rose about 24.74%, while Arista Networks cli...
A practical, investor-focused look at Kestra Medical's (KMTS) 2026 earnings trajectory. We unpack expected revenue dr...
IBM's latest profit warning sheds light on the strength and limits of AI demand, cloud growth, and enterprise spendin...
Netflix just posted a record quarterly revenue, but the forecast for the next quarter came in softer than expected. H...
A bold forecast from Nvidia's founder centers on an AI spending boom. This article breaks down the rationale, the mat...
Disney trades at a notably lower multiple than Netflix, but the reasons go beyond simple numbers. This guide breaks d...
January payrolls rose 130,000 with the jobless rate at 4.3%, while revisions to prior months add uncertainty as trade...
A surge in crypto funding surging again accompanies a strategic pivot by major VCs toward infrastructure and tokenize...
Snap enters 2026 with a volatile but potentially rewarding path. Analysts weigh user growth, ad monetization, and new...